| [1] |
Amiri M，Janssen F，Kunst AE.The decline in stomach cancer mortality：exploration of future trends in seven European countries[J]．Eur J Epidemiol，2011，26(1)：23-28.
|
| [2] |
Rahman R，Asombang AW，Ibdah JA.Characteristics of gastric cancer in Asia[J]．World J Gastroenterol，2014，20(16)：4483-4490.
|
| [3] |
Cancer Research UK.Stomach cancer statistics| Cancer Research UK [Internet]. 2016.cited 14 Mar 2018)．
URL
|
| [4] |
Song H，Held M，Sandin S，et al.Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in northern Sweden between 1990 and 2009[J]．Clin Gastroenterol Hepatol，2015，13(9)：1592-1600.
|
| [5] |
Anderson WF，Camargo MC，Fraumeni JF，et al.Age-specific trends in incidence of noncardia gastric cancer in US adults[J]．JAMA，2010，303(17)：1723-1728.
|
| [6] |
Maconi G，Manes G，Porro GB.Role of symptoms in diagnosis and outcome of gastric cancer[J]．World J Gastroenterol，2008，14(8)：1149-1155.
|
| [7] |
Matsuda T，Saika K．The 5-year relative survival rate of stomach cancer in the USA，Europe and Japan[J]．Jpn J Clin Oncol，2013，43(11)：1157-1158.
|
| [8] |
Correa P，Haenszel W，Cuello C，et al.A model for gastric cancer epidemiology [J]．Lancet，1975，2(7924)：58-60.
|
| [9] |
Correa P．A human model of gastric carcinogenesis[J]．Cancer Res，1988，48(13)：3554-3560.
|
| [10] |
Dinis-Ribeiro M，Areia M，de Vries AC，et al.Management of precancerous conditions and lesions in the stomach (MAPS)：guideline from the European Society of Gastrointestinal Endoscopy (ESGE)，European Helicobacter Study Group (EHSG)，European Society of Pathology (ESP)，and the Sociedade Portuguesa de EndoscopiaDigestiva (SPED)[J]．Endoscopy，2012，44(1)：74-94.
|
| [11] |
Tham TC，Gleeson D，Greenfield SM，et al.British Society of Gastroenterology policy and processes for the development of guidelines[J]．Gut，2015，64(7)：1184- 1185.
|
| [12] |
Appraisal of guidelines for research & evaluation II.The AGREE Research Trust. Update：September 2013.
URL
|
| [13] |
Spence AD，Cardwell CR，McMenamin ÙC，et al.Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review[J]．BMC Gastroenterol，2017，17(1)：157.
|
| [14] |
Guyatt GH，Oxman AD，Vist GE，et al.GRADE：an emerging consensus on rating quality of evidence and strength of recommendations[J]．BMJ，2008，336(7650)：924-926.
|
| [15] |
Song H，Ekheden IG，Zheng Z，et al.Incidence of gastric cancer among patients with gastric precancerous lesions：observational cohort study in a low risk Western population[J]．BMJ，2015，351：h3867.
|
| [16] |
Miwata T，Quach DT，Hiyama T，et al.Interobserver and intraobserver agreement for gastric mucosa atrophy[J]．BMC Gastroenterol，2015，15：95.
|
| [17] |
Leja M，Funka K，Janciauskas D，et al.Interobserver variation in assessment of gastric premalignant lesions：higher agreement for intestinal metaplasia than for atrophy[J]．Eur J Gastroenterol Hepatol，2013，25(6)：694-699.
|
| [18] |
Toyoshima O，Yamaji Y，Yoshida S，et al.Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication [J]．Surg Endosc，2017，31(5)：2140-2148.
|
| [19] |
Webb PM，Hengels KJ，Møller H，et al.The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group[J]．Gastroenterology，1994，107(5)：1335-1344.
|
| [20] |
Weck MN.Prevalence of chronic atrophic gastritis in different parts of the world[J]．Cancer Epidemiol Biomarkers Prev，2006，15(6)：1083-1094.
|
| [21] |
Choi CE，Sonnenberg A，Turner K，et al.High prevalence of gastric preneoplastic lesions in East Asians and Hispanics in the USA[J]．Dig Dis Sci，2015，60(7)：2070-2076.
|
| [22] |
Namekata T，Miki K，Kimmey M，et al.Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle[J]．Am J Epidemiol，2000，151(8)：820-830.
|
| [23] |
Adamu MA，Weck MN，Gao L，et al.Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies[J]．Eur J Epidemiol，2010，25(7)：439-448.
|
| [24] |
Vannella L，Lahner E，Annibale B．Risk for gastric neoplasias in patients with chronic atrophic gastritis：a critical reappraisal[J]．World J Gastroenterol，2012，18(12)：1279-1285.
|
| [25] |
de Vries AC，van Grieken NC，Looman CW，et al.Gastric cancer risk in patients with premalignant gastric lesions：a nationwide cohort study in the Netherlands [J]．Gastroenterology，2008，134(4)：945-952.
|
| [26] |
Shichijo S，Hirata Y，Niikura R，et al.Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication[J]．Gastrointest Endosc，2016，84(4)：618-624.
|
| [27] |
Eriksson NK，Kärkkäinen PA，Färkkilä MA，et al.Prevalence and distribution of gastric intestinal metaplasia and its subtypes[J]．Dig Liver Dis，2008，40(5)：355-360.
|
| [28] |
Olmez S，Aslan M，Erten R，et al.The prevalence of gastric intestinal metaplasia and distribution of Helicobacter pylori infection，atrophy，dysplasia，and cancer in its subtypes[J]．Gastroenterol Res Pract，2015，2015：1-6.
|
| [29] |
Eidt S，Stolte M．Prevalence of intestinal metaplasia in Helicobacter pylori gastritis[J]．Scand J Gastroenterol，1994，29(7)：607-610.
|
| [30] |
Tulassay Z，Stolte M，Engstrand L，et al.Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pyloripositive patients with gastric ulcers[J]．Scand J Gastroenterol, 2010，45(9)：1048-1058.
|
| [31] |
Uemura N，Okamoto S，Yamamoto S，et al.Helicobacter pylori infection and the development of gastric cancer[J]．N Engl J Med Overseas Ed，2001，345(2)：784-789.
|
| [32] |
Zullo A，Hassan C，Romiti A，et al.Follow-up of intestinal metaplasia in the stomach：when，how and why[J]．World J Gastrointest Oncol，2012，4(3)：30-36.
|
| [33] |
Park YH，Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer[J]．J Cancer Prev，2015，20(1)：25-40.
|
| [34] |
González CA，Sanz-Anquela JM，Companioni O，et al.Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer：results of the Spanish follow-up multicenter study[J]．J Gastroenterol Hepatol，2016，31(5)：953-958.
|
| [35] |
Dinis-Ribeiro M，Lopes C，da Costa-Pereira A，et al.A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia[J]．J Clin Pathol，2004，57(2)：177-182.
|
| [36] |
Cassaro M，Rugge M，Gutierrez O，et al.Topographic patterns of intestinal metaplasia and gastric cancer[J]．Am J Gastroenterol，2000，95(6)：1431-1438.
|
| [37] |
Vannella L，Lahner E，Osborn J，et al.Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis[J]．Aliment Pharmacol Ther，2010，31(9)：1042-1050.
|
| [38] |
Lahner E，Bordi C，Cattaruzza MS，et al.Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection[J]．Aliment Pharmacol Ther，2005，22(5)：471-481.
|
| [39] |
Rugge M，Fassan M，Pizzi M，et al.Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment[J]．World J Gastroenterol，2011，17(41)：4596-4601.
|
| [40] |
Capelle LG，de Vries AC，Haringsma J，et al.The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis[J]．Gastrointest Endosc，2010，71(7)：1150-1158.
|
| [41] |
Weston AP，Krmpotich P，Makdisi WF，et al.Short segment Barrett's esophagus: clinical and histological features，associated endoscopic findings，and association with gastric intestinal metaplasia[J]．Am J Gastroenterol，1996，91(5)：981-986.
|
| [42] |
Johnston MH，Hammond AS，Laskin W，et al.The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy[J]．Am J Gastroenterol，1996，91(8)：1507-1511.
|
| [43] |
Sharma P，Weston AP，Morales T，et al.Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia[J]．Gut，2000，46(1)：9-13.
|
| [44] |
Sung JK.Diagnosis and management of gastric dysplasia[J]．Korean J Intern Med，2016，31(2)：201-209.
|
| [45] |
Lauwers GY，Riddell RH. Gastric epithelial dysplasia[J]．Gut，1999，45(5)：784.
|
| [46] |
Kim JW，Jang JY.Optimal management of biopsy-proven low-grade gastric dysplasia[J]．World J Gastrointest Endosc，2015，7(4)：396-402.
|
| [47] |
Baek DH，Kim GH，Park DY，et al.Gastric epithelial dysplasia: characteristics and long-term follow-up results after endoscopic resection according to morphological categorization[J]．BMC Gastroenterol，2015，15：17.
|
| [48] |
Shin CM，Kim N，Yang HJ，et al.Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer[J]．J Clin Gastroenterol，2010，44(2)：e34-39.
|
| [49] |
Lissowska J，Groves FD，Sobin LH，et al.Family history and risk of stomach cancer in Warsaw，Poland[J]．Eur J Cancer Prev，1999，8(3)：223-227.
|
| [50] |
Nagase H，Ogino K，Yoshida I，et al.Family history-related risk of gastric cancer in Japan：a hospital-based case-control study[J]．Jpn J Cancer Res，1996，87(10)：1025-1028.
|
| [51] |
Jiang X，Tseng CC，Bernstein L，et al.Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas：a case-control study[J]．BMC Cancer，2014，4：60.
|
| [52] |
Kwak HW，Choi IJ，Kim CG，et al.Individual having a parent with early-onset gastric cancer may need screening at younger age[J]．World J Gastroenterol，2015，21(15)：4592-4598.
|
| [53] |
Reddy KM，Chang JI，Shi JM，et al.Risk of gastric cancer among patients with intestinal metaplasia of the stomach in a US integrated health care system[J]．Clin Gastroenterol Hepatol，2016，14(10)：1420-425.
|
| [54] |
Lichtenstein P，Holm NV，Verkasalo PK，et al.Environmental and heritable factors in the causation of cancer analyses of cohorts of twins from Sweden, Denmark，and Finland[J]．N Engl J Med Overseas Ed，2000，343(2)：78-85.
|
| [55] |
Oliveira C，Pinheiro H，Figueiredo J，et al.Familial gastric cancer：genetic susceptibility，pathology，and implications for management[J]．Lancet Oncol，2015，16(2)：e60-e70.
|
| [56] |
Rudloff U．Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives[J]．Clin Exp Gastroenterol，2018，11：447-459.
|
| [57] |
Repak R，Kohoutova D，Podhola M，et al.The first European family with gastric adenocarcinoma and proximal polyposis of the stomach：case report and review of the literature[J]．Gastrointest Endosc，2016，84(4)：718-725.
|
| [58] |
Capelle LG，Van Grieken NC，Lingsma HF，et al.Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands[J]. Gastroenterology，2010，138(2)：487-492.
|
| [59] |
Heald B，Mester J，Rybicki L，et al.Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers[J]. Gastroenterology，2010，139(6)：1927-1933.
|
| [60] |
Syngal S，Brand RE，Church JM，et al.ACG clinical guideline：Genetic testing and management of hereditary gastrointestinal cancer syndromes[J]．Am J Gastroenterol，2015，110(2)：223-262.
|
| [61] |
Kluijt I，Sijmons RH，Hoogerbrugge N，et al.Familial gastric cancer: guidelines for diagnosis，treatment and periodic surveillance[J]．Fam Cancer，2012，11(3)：363-369.
|
| [62] |
van der Post RS，Vogelaar IP，Carneiro F，et al.Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers[J]．J Med Genet，2015，52(6)：361-374.
|
| [63] |
Fitzgerald RC，Hardwick R，Huntsman D，et al.Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research[J]．J Med Genet，2010，47(7)：436-444.
|
| [64] |
Persson C，Canedo P，Machado JC，et al.Polymorphisms in inflammatory response genes and their association with gastric cancer：a HuGE systematic review and metaanalyses[J]．Am J Epidemiol，2011，173(3)：259-270.
|
| [65] |
Vannella L，Lahner E，Osborn J，et al.Systematic review：gastric cancer incidence in pernicious anaemia[J]．Aliment Pharmacol Ther，2013，37(4)：375-382.
|
| [66] |
Murphy G，Dawsey SM，Engels EA，et al.Cancer risk after pernicious anemia in the US elderly population[J]．Clin Gastroenterol Hepatol，2015，13(13)：2282-2289.
|
| [67] |
Rusak E，Chobot A，Krzywicka A，et al.Anti-parietal cell antibodies diagnostic significance[J]．Adv Med Sci，2016，61(2)：175-179.
|
| [68] |
Minalyan A，Benhammou JN，Artashesyan A，et al.Autoimmune atrophic gastritis：current perspectives[J]．Clin Exp Gastroenterol，2017，10：19-27.
|
| [69] |
Fisher SG，Davis F，Nelson R，et al.A cohort study of stomach cancer risk in men after gastric surgery for benign disease[J]．J Natl Cancer Inst，1993，85(16)：1303- 1310.
|
| [70] |
Tersmette AC，Goodman SN，Offerhaus GJ，et al.Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients[J]．Am J Epidemiol，1991，134(1)：14-21.
|
| [71] |
Viste A，Bj？rnestad E，Opheim P，et al.Risk of carcinoma following gastric operations for benign disease.A historical cohort study of 3470 patients[J]．Lancet，1986，2(8505)：502-505.
|
| [72] |
Schafer LW，Larson DE，Melton LJ，et al.The risk of gastric carcinoma after surgical treatment for benign ulcer disease.A population-based study in Olmsted County，Minnesota[J]．N Engl J Med，1983，309(20)：1210-1213.
|
| [73] |
Lagergren J，Lindam A，Mason RM.Gastric stump cancer after distal gastrectomy for benign gastric ulcer in a population-based study[J]．Int J Cancer，2012，131(6)：E1048-E1052.
|
| [74] |
Jemal A，Siegel R，Ward E，et al.Cancer statistics，2006[J]．CA Cancer J Clin，2006，56(2)：106-130.
|
| [75] |
Ali R，Barnes I，Cairns BJ，et al.Incidence of gastrointestinal cancers by ethnic group in England，2001-2007[J]．Gut，2013，62(12)：1692-1703.
|
| [76] |
Lui FH，Tuan B，Swenson SL，et al.Ethnic disparities in gastric cancer incidence and survival in the USA：an updated analysis of 1992-2009 SEER data[J]．Dig Dis Sci，2014，59(12)：3027-3034.
|
| [77] |
Jin H，Pinheiro PS，Xu J，et al.Cancer incidence among Asian American populations in the United States，2009-2011[J]．Int J Cancer，2016，138(9)：2136-2145.
|
| [78] |
Dong E，Duan L，Wu BU.Racial and ethnic minorities at increased risk for gastric cancer in a regional US population study[J]．Clin Gastroenterol Hepatol，2017，15(4)：511-517.
|
| [79] |
Pérez-Rodríguez M，Partida-Rodríguez O，Camorlinga-Ponce M，et al. Polymorphisms in HLA-DQ genes，together with age，sex，and Helicobacter pylori infection，as potential biomarkers for the early diagnosis of gastric cancer[J]. Helicobacter，2017，22(1)：e12326.
|
| [80] |
Lee TY，Wang RC，Lee YC，et al.The incidence of gastric adenocarcinoma among patients with gastric intestinal metaplasia：a long-term cohort study[J]．J Clin Gastroenterol，2016，50(7)：532-537.
|
| [81] |
Leung WK，Lin SR，Ching JY，et al.Factors predicting progression of gastric intestinal metaplasia：results of a randomised trial on Helicobacter pylori eradication [J]．Gut，2004，53(9)：1244-1249.
|
| [82] |
You WC，Li JY，Blot WJ，et al.Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer[J]．Int J Cancer，1999，83(5)：615-619.
|
| [83] |
Theuer CP，de Virgilio C，Keese G，et al.Gastric adenocarcinoma in patients 40 years of age or younger[J]．Am J Surg，1996，172(5)：473-477.
|
| [84] |
Engel LS，Chow WH，Vaughan TL，et al.Population attributable risks of esophageal and gastric cancers[J]．J Natl Cancer Inst，2003，95(18)：1404-1413.
|
| [85] |
Sjödahl K，Lu Y，Nilsen TI，et al.Smoking and alcohol drinking in relation to risk of gastric cancer：a population-based，prospective cohort study[J]．Int J Cancer，2007，120(1)：128-132.
|
| [86] |
Nomura AMY，Wilkens LR，Henderson BE，et al.The association of cigarette smoking with gastric cancer：the multiethnic cohort study[J]．Cancer Causes Control，2012，23(1)：51-58.
|
| [87] |
Morais S，Rodrigues S，Amorim L，et al.Tobacco smoking and intestinal metaplasia：systematic review and meta-analysis[J]．Dig Liver Dis，2014，46(11)：1031-1037.
|
| [88] |
Song H，Zhu J，Lu D．Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions[J]．Cochrane Database Syst Rev，2014，12：CD010623.
|
| [89] |
Ge Z，Ben Q，Qian J，et al.Diabetes mellitus and risk of gastric cancer：a systematic review and meta-analysis of observational studies[J]．Eur J Gastroenterol，Hepatol，2011，23(12)：1127-1135.
|
| [90] |
Tramacere I，Negri E，Pelucchi C，et al.A meta-analysis on alcohol drinking and gastric cancer risk[J]．Ann Oncol，2012，23(1)：28-36.
|
| [91] |
Lin XJ，Wang CP，Liu XD，et al.Body mass index and risk of gastric cancer: a metaanalysis[J]．Jpn J Clin Oncol，2014，44(9)：783-791.
|
| [92] |
Brusselaers N，Wahlin K，Engstrand L，et al.Maintenance therapy with proton pump inhibitors and risk of gastric cancer：a nationwide population-based cohort study in Sweden[J]．BMJ Open，2017，7(10)：e017739.
|
| [93] |
Cheung KS，Chan EW，Wong AYS，et al.Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori：a population based study[J]．Gut，2018，67(1)：28-35.
|
| [94] |
Schneider JL，Kolitsopoulos F，Corley DA.Risk of gastric cancer, gastrointestinal cancers and other cancers：a comparison of treatment with pantoprazole and other proton pump inhibitors[J]．Aliment Pharmacol Ther，2016，43(1)：73-82.
|
| [95] |
BSG Position Statement - Proton pump inhibitors (PPIs) and the risk of gastric cancer[Internet]．cited 27 Jan 2019)．
URL
|
| [96] |
Cai X，Carlson J，Stoicov C，et al.Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice[J]. Gastroenterology，2005，128(7)：1937-1952.
|
| [97] |
Lee CW，Rickman B，Rogers AB，et al.Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice[J]．Cancer Res，2008，68(9)：3540-3548.
|
| [98] |
Ford AC，Forman D，Hunt RH，et al.Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals：systematic review and meta-analysis of randomised controlled trials[J]．BMJ，2014，348：g3174.
|
| [99] |
Ford AC，Forman D，Hunt R，et al.Helicobacter pylori eradication for the prevention of gastric neoplasia[J]．Cochrane Database Syst Rev，2015，7：CD005583.
|
| [100] |
Doorakkers E，Lagergren J，Engstrand L，et al.Eradication of Helicobacter pylori and gastric cancer：a systematic review and meta-analysis of cohort studies[J]．J Natl Cancer Inst，2016，108(9)：djw132.
|
| [101] |
Lee YC，Chiang TH，Chou CK，et al.Association between Helicobacter pylori eradication and gastric cancer incidence：a systematic review and meta-analysis[J]. Gastroenterology，2016，150(5)：1113-1124.
|
| [102] |
O'Connor A，O'Morain CA，Ford AC.Population screening and treatment of Helicobacter pylori infection[J]．Nat Rev Gastroenterol Hepatol，2017，14(4)：230- 240.
|
| [103] |
Pan KF，Zhang L，Gerhard M，et al.A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China：baseline results and factors affecting the eradication[J]．Gut，2016，65(1)：9-18.
|
| [104] |
Chen HN，Wang Z，Li X，et al.Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia：evidence from a meta-analysis[J]．Gastric Cancer，2016，19(1)：166-175.
|
| [105] |
Rokkas T，Rokka A，Portincasa P．A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer[J]．Ann Gastroenterol，2017，30(4)：414-423.
|
| [106] |
Choi IJ，Kook MC，Kim YI，et al.Helicobacter pylori therapy for the prevention of metachronous gastric cancer[J]．N Engl J Med Overseas Ed，2018，378(12)：1085-1095.
|
| [107] |
Goddard AF，Badreldin R，Pritchard DM，et al.British Society of Gastroenterology.The management of gastric polyps[J]．Gut，2010，59(9)：1270-1276.
|
| [108] |
Ohkusa T，Miwa H，Hojo M，et al.Endoscopic，histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases[J]．Digestion，2003，68(2-3)：57-62.
|
| [109] |
Ohkusa T，Takashimizu I，Fujiki K，et al.Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori.A randomized，clinical trial[J]. Ann Intern Med，1998，129(9)：712-715.
|
| [110] |
Ji F，Wang ZW，Ning JW，et al.Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori：a randomized，controlled trial[J]．World J Gastroenterol，2006，12(11)：1770-1773.
|
| [111] |
Ljubicic N，Banic M，Kujundzic M，et al.The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps[J]．Eur J Gastroenterol Hepatol，1999，11(7)：727-730.
|
| [112] |
Huang YK，Yu JC，Kang WM，et al.Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening：a systematic review and metaanalysis[J]．PLoS One，2015，10(11)：e0142080.
|
| [113] |
Yeh JM，Hur C，Ward Z，et al.Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies：a cost-effectiveness analysis[J]．Gut，2016，65(4)：563-574.
|
| [114] |
Kuipers EJ.In through the out door：serology for atrophic gastritis[J]．Eur J Gastroenterol Hepatol，2003，15(8)：877-879.
|
| [115] |
Lomba-Viana R，Dinis-Ribeiro M，Fonseca F，et al.Serum pepsinogen test for early detection of gastric cancer in a European country[J]．Eur J Gastroenterol Hepatol，2012，24(1)：37-41.
|
| [116] |
Miki K，Fujishiro M，Kodashima S，et al.Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population[J]．Dig Endosc，2009，21(2)：78-81.
|
| [117] |
Dinis-Ribeiro M，Yamaki G，Miki K，et al.Meta-analysis on the validity of pepsinogen test for gastric carcinoma，dysplasia or chronic atrophic gastritis screening[J]．J Med Screen，2004，11(3)：141-1417.
|
| [118] |
Broutet N，Plebani M，Sakarovitch C，et al.Pepsinogen A，pepsinogen C，and gastrin as markers of atrophic chronic gastritis in European dyspeptics[J]．Br J Cancer，2003，88(8)：1239-1247.
|
| [119] |
Terasawa T，Nishida H，Kato K，et al.Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians：a systematic review and meta-analysis[J]．PLoS One，2014，9(10)：e109783.
|
| [120] |
Yamaguchi Y，Nagata Y，Hiratsuka R，et al.Gastric cancer screening by combined assay for serum anti-Helicobacter pylori igG antibody and serum pepsinogen levelstheabc method[J]．Digestion，2016，93(1)：13-18.
|
| [121] |
Lansdorp-Vogelaar I，Kuipers EJ.Screening for gastric cancer in Western countries[J]．Gut，2016，65(4)：543-544.
|
| [122] |
Ikeda F，Shikata K，Hata J，et al.Combination of Helicobacter pylori antibody and serum pepsinogen as a good predictive tool of gastric cancer incidence：20-year prospective data from the Hisayama study[J]．J Epidemiol，2016，26(12)：629-636.
|
| [123] |
Zagari RM，Rabitti S，Greenwood DC，et al.Systematic review with meta- analysis：diagnostic performance of the combination of pepsinogen，gastrin-17 and antiHelicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis[J]．Aliment Pharmacol Ther，2017，46(7)：657-667.
|
| [124] |
McNicholl AG，Forné M，Barrio J，et al.Accuracy of GastroPanel for the diagnosis of atrophic gastritis[J]．Eur J Gastroenterol Hepatol，2014，26(9)：941-948.
|
| [125] |
Masci E，Pellicano R，Mangiavillano B，et al.GastroPanel? test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia[J]．Minerva Gastroenterol Dietol，2014，60(1)：79-83.
|
| [126] |
Compare D，Rocco A，Nardone G．Screening for and surveillance of gastric cancer[J]．World J Gastroenterol，2014，20(38)：13681-13691.
|
| [127] |
Amal H，Leja M，Funka K，et al.Detection of precancerous gastric lesions and gastric cancer through exhaled breath[J]．Gut，2016，65(3)：400-407.
|
| [128] |
Menon S, Trudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis[J]．Endosc Int Open，2014，2(2)：E46-50.
|
| [129] |
Beg S，Ragunath K，Wyman A，et al.Quality standards in upper gastrointestinal endoscopy：a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS)[J]．Gut，2017，66(11)：1886-1899.
|
| [130] |
Bisschops R，Areia M，Coron E，et al.Performance measures for upper gastrointestinal endoscopy：a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative[J]．Endoscopy，2016，48(9)：843-864.
|
| [131] |
Teh JL，Tan JR，Lau LJ，et al.Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy[J]．Clin Gastroenterol Hepatol，2015，13(3)：480-487.
|
| [132] |
Teh JL，Hartman M，Lau L，et al.Mo1579 duration of endoscopic examination significantly impacts detection rates of neoplastic lesions during diagnostic upper endoscopy[J]．Gastrointest Endosc，2011，73(4)：AB393.
|
| [133] |
Taga S．Endoscopy technique.Observation by panendoscopy.In：Tada M, Maruyama M，Fujino M，eds.I to Cho Handbook.Tokyo：Igakushoin，1992：132-139.
|
| [134] |
JSGCS.The committee for standardizing screening gastroscopy.Gastric cancer screeing techniques.Handbook.1st ed.Tokyo：Igakushoin，2010.
|
| [135] |
Yao K．The endoscopic diagnosis of early gastric cancer[J]．Ann Gastroenterol，2013，26(1)：11-22.
|
| [136] |
Zhang Q，Chen Z，Chen C，et al.Training in early gastric cancer diagnosis improves the detection rate of early gastric cancer[J]．Medicine (Baltimore)，2015，94(2)：e384.
|
| [137] |
Yao K，Uedo N，Muto M，et al.Development of an e-learning system for teaching endoscopists how to diagnose early gastric cancer：basic principles for improving early detection[J]．Gastric Cancer，2017，20(Suppl 1)：28-38.
|
| [138] |
Yao K，Uedo N，Muto M，et al.Development of an e-learning system for the endoscopic diagnosis of early gastric cancer：an international multicenter randomized controlled trial[J]．EBioMedicine，2016，9：140-147.
|
| [139] |
Nakanishi H，Doyama H，Ishikawa H，et al.Evaluation of an e-learning system for diagnosis of gastric lesions using magnifying narrow-band imaging：a multicenter randomized controlled study[J]．Endoscopy，2017，49(10)：957-967.
|
| [140] |
Yagi K，Aruga Y，Nakamura A，et al.Regular arrangement of collecting venules (RAC)：a characteristic endoscopic feature of Helicobacter pylori-negative normal stomach and its relationship with esophago-gastric adenocarcinoma[J]．J Gastroenterol，2005，40(5)：443-452.
|
| [141] |
Yagi K，Honda H，Yang JM，et al.Magnifying endoscopy in gastritis of the corpus[J]．Endoscopy，2005，37(7)：660-666.
|
| [142] |
Yagi K，Nakamura A，Sekine A．Comparison between magnifying endoscopy and histological，culture and urease test findings from the gastric mucosa of the corpus[J]．Endoscopy，2002，34(5)：376-381.
|
| [143] |
Cho JH，Chang YW，Jang JY，et al.Close observation of gastric mucosal pattern by standard endoscopy can predict Helicobacter pylori infection status[J]．J Gastroenterol Hepatol，2013，28(2)：279-284.
|
| [144] |
Na S，Chung JW，Park HJ，et al.The usefulness of the regular arrangement of collecting venules pattern for the determination of Helicobacter pylori Infection[J]．Korean J Gastroenterol，2011，58(5)：252.
|
| [145] |
Machado RS，Viriato A，Kawakami E，et al.The regular arrangement of collecting venules pattern evaluated by standard endoscope and the absence of antrum nodularity are highly indicative of Helicobacter pylori uninfected gastric mucosa[J]．Dig Liver Dis，2008，40(1)：68-72.
|
| [146] |
Muto M，Yao K，Kaise M，et al.Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G) [J]．Dig Endosc，2016，28(4)：379-393.
|
| [147] |
Bansal A，Ulusarac O，Mathur S，et al.Correlation between narrow band imaging and nonneoplastic gastric pathology：a pilot feasibility trial[J]．Gastrointest Endosc，2008，67(2)：210-216.
|
| [148] |
Uedo N．Advanced imaging in the diagnosis of gastric intestinal metaplasia：the expert's approach[J]．Video Journal and Encyclopedia of GI Endoscopy，2013，1(1)：112-114.
|
| [149] |
Anagnostopoulos GK，Yao K，Kaye P，et al.High-resolution magnification endoscopy can reliably identify normal gastric mucosa，Helicobacter pylori-associated gastritis，and gastric atrophy[J]．Endoscopy，2007，39(3)：202-207.
|
| [150] |
Pimentel-Nunes P，Dinis-Ribeiro M，Soares JB，et al.A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions[J]．Endoscopy，2012，44(3)：236-246.
|
| [151] |
Gonen C，Simsek I，Sarioglu S，et al.Comparison of high resolution magnifying endoscopy and standard videoendoscopy for the diagnosis of Helicobacter pylori gastritis in routine clinical practice：a prospective study[J]．Helicobacter，2009，14(1)：12-21.
|
| [152] |
Uedo N，Yao K．Endoluminal diagnosis of early gastric cancer and its precursors: bridging the gap between endoscopy and pathology[J]．Adv Exp Med Biol，2016，908：293-316.
|
| [153] |
Yao K，Iwashita A，Tanabe H，et al.White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow band imaging：a new optical sign for differentiating between adenoma and carcinoma[J]．Gastrointest Endosc，2008，68(3)：574-580.
|
| [154] |
Nakayama Y，Horiuchi A，Kumagai T，et al.Discrimination of normal gastric mucosa from Helicobacter pylori gastritis using standard endoscopes and a single observation site：studies in children and young adults[J]．Helicobacter，2004，9(2)：95-99.
|
| [155] |
Redéen S，Petersson F，J？nsson KA，et al.Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample[J]．Endoscopy，2003，35(11)：946-950.
|
| [156] |
Kimura K，Takemoto T．An endoscopic recognition of the atrophic border and its significance in chronic gastritis[J]．Endoscopy，1969，1：87-97.
|
| [157] |
Naylor GM，Gotoda T，Dixon M，et al.Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients[J]．Gut，2006，55(11)：1545-1552.
|
| [158] |
Kono S，Gotoda T，Yoshida S，et al.Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan[J]．World J Gastroenterol, 2015，21(46)：13113-13123.
|
| [159] |
Nagata N，Shimbo T，Akiyama J，et al.Predictability of gastric intestinal metaplasia by mottled patchy erythema seen on endoscopy[J]．Gastroenterology Res，2011，4(5)：203-209.
|
| [160] |
Lim JH，Kim N，Lee HS，et al.Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia[J]．Gut Liver，2013，7(1)：41-50.
|
| [161] |
Panteris V，Nikolopoulou S，Lountou A，et al.Diagnostic capabilities of highdefinition white light endoscopy for the diagnosis of gastric intestinal metaplasia and correlation with histologic and clinical data[J]．Eur J Gastroenterol Hepatol，2014，26(6)：1-601.
|
| [162] |
Pimentel-Nunes P，Libânio D，Lage J，et al.A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions[J]．Endoscopy，2016，48(8)：723-730.
|
| [163] |
Kikuste I，Stirna D，Liepniece-Karele I，et al.The accuracy of flexible spectral imaging colour enhancement for the diagnosis of gastric intestinal metaplasia：do we still need histology to select individuals at risk for adenocarcinoma？[J]．Eur J Gastroenterol Hepatol，2014，26(7)：704-709.
|
| [164] |
Ang TL，Pittayanon R，Lau JY，et al.A multicenter randomized comparison between high-definition white light endoscopy and narrow band imaging for detection of gastric lesions[J]．Eur J Gastroenterol Hepatol，2015，27(12)：1473-1478.
|
| [165] |
Buxbaum JL，Hormozdi D，Dinis-Ribeiro M，et al.Narrow-band imaging versus white light versus mapping biopsy for gastric intestinal metaplasia：a prospective blinded trial[J]．Gastrointest Endosc，2017，86(5)：857-865.
|
| [166] |
Uedo N，Ishihara R，Iishi H，et al.A new method of diagnosing gastric intestinal metaplasia：narrow-band imaging with magnifying endoscopy[J]．Endoscopy，2006，38(8)：819-824.
|
| [167] |
An JK，Song GA，Kim GH，et al.Marginal turbid band and light blue crest, signs observed in magnifying narrow-band imaging endoscopy，are indicative of gastric intestinal metaplasia[J]．BMC Gastroenterol，2012，12：169.
|
| [168] |
Kanemitsu T，Yao K，Nagahama T，et al.Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach：the white opaque substance marker[J]．Endoscopy，2017，49(6)：529-535.
|
| [169] |
Wang L，Huang W，Du J，et al.Diagnostic yield of the light blue crest sign in gastric intestinal metaplasia：a meta-analysis[J]．PLoS One，2014，9(3)：e92874.
|
| [170] |
Eshmuratov A，Nah JC，Kim N，et al.The correlation of endoscopic and histological diagnosis of gastric atrophy[J]．Dig Dis Sci，2010，55(5)：1364-1375.
|
| [171] |
Zhang Q，Wang F，Chen ZY，et al.Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer：a meta-analysis[J]．Gastric Cancer，2016，19(2)：543-552.
|
| [172] |
Libânio D，Braga V，Ferraz S，et al.Prospective comparative study of endoscopic submucosal dissection and gastrectomy for early neoplastic lesions including patients' perspectives[J]．Endoscopy，2019，51(1)：30-39.
|
| [173] |
Axon A．Symptoms and diagnosis of gastric cancer at early curable stage[J]．Best Pract Res Clin Gastroenterol，2006，20(4)：697-708.
|
| [174] |
Coda S，Lee SY，Gotoda T．Endoscopic mucosal resection and endoscopic submucosal dissection as treatments for early gastrointestinal cancers in Western countries[J]．Gut Liver，2007，1(1)：12-21.
|
| [175] |
Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract[J]．Endoscopy，2005，37(6)：570-578.
|
| [176] |
Veitch AM，Uedo N，Yao K，et al.Optimizing early upper gastrointestinal cancer detection at endoscopy[J]．Nat Rev Gastroenterol Hepatol，2015，12(11)：660-667.
|
| [177] |
Lauwers GY.Defining the pathologic diagnosis of metaplasia，atrophy，dysplasia, and gastric adenocarcinoma[J]．J Clin Gastroenterol，2003，36(5 Suppl)：S37-43.
|
| [178] |
Park DY，Srivastava A，Kim GH，et al.Adenomatous and foveolar gastric dysplasia：distinct patterns of mucin expression and background intestinal metaplasia[J]．Am J Surg Pathol，2008，32(4)：524-533.
|
| [179] |
Correa P，Haenszel W，Cuello C，et al.Gastric precancerous process in a high risk population：cohort follow-up[J]．Cancer Res，1990，50(15)：4737-4740.
|
| [180] |
Uedo N，Iishi H，Tatsuta M，et al.Longterm outcomes after endoscopic mucosal resection for early gastric cancer[J]．Gastric Cancer，2006，9(2)：88-92.
|
| [181] |
Rokkas T，Filipe MI，Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up[J]．Gut，1991，32(10)：1110-1113.
|
| [182] |
Whiting JL，Sigurdsson A，Rowlands DC，et al.The long term results of endoscopic surveillance of premalignant gastric lesions[J]．Gut，2002，50(3)：378-381.
|
| [183] |
den HollanderWJ，Holster IL，den Hoed CM，et al.Surveillance of premalignant gastric lesions：a multicentre prospective cohort study from low incidence regions[J]．Gut，2019，68(4)：585-593.
|
| [184] |
Yeh JM，Hur C，Kuntz KM，et al.Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer[J]．Cancer，2010，116(12)：2941-2953.
|
| [185] |
Areia M，Dinis-Ribeiro M，Rocha Gon？alves F．Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions[J]．Helicobacter，2014，19(6)：425-436.
|
| [186] |
Zhou HJ，Dan YY，Naidoo N，et al.A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk[J]．PLoS One，2013，8(12)：e83959.
|
| [187] |
Wu JT，Zhou J，Naidoo N，et al.Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions[J]．Asia Pac J Clin Oncol，2016，12(4)：359-368.
|
| [188] |
Di Gregorio C，Morandi P，Fante R，et al.Gastric dysplasia.A follow-up study[J]．Am J Gastroenterol，1993，88(10)：1714-1719.
|
| [189] |
Fertitta AM，Comin U，Terruzzi V，et al.Clinical significance of gastric dysplasia: a multicenter follow-up study.Gastrointestinal Endoscopic Pathology Study Group[J]．Endoscopy，1993，25(4)：265-268.
|
| [190] |
Yamada H，Ikegami M，Shimoda T，et al.Long-term follow-up study of gastric adenoma/dysplasia[J]．Endoscopy，2004，36(5)：390-396.
|
| [191] |
Rugge M，Cassaro M，Di Mario F，et al.The long term outcome of gastric noninvasive neoplasia[J]．Gut，2003，52(8)：1111-1116.
|
| [192] |
Park SY，Jeon SW，Jung MK，et al.Long-term follow-up study of gastric intraepithelial neoplasias：progression from low-grade dysplasia to invasive carcinoma[J]．Eur J Gastroenterol Hepatol，2008，20(10)：966-970.
|
| [193] |
Kokkola A，Haapiainen R，Laxén F，et al.Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis：a follow up study[J]．J Clin Pathol，1996，49(12)：979-984.
|
| [194] |
Rugge M，Farinati F，Baffa R，et al.Gastric epithelial dysplasia in the natural history of gastric cancer：a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia[J]．Gastroenterology，1994，107(5)：1288-1296.
|
| [195] |
Simone A，Casadei A，De Vergori E，et al.Rescue endoscopy to identify site of gastric dysplasia or carcinoma found at random biopsies[J]．Dig Liver Dis，2011，43(9)：721-725.
|
| [196] |
Abraham SC，Park SJ，Lee JH，et al.Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes[J]．Mod Pathol，2003，16(8)：786-795.
|
| [197] |
Zhao G，Xue M，Hu Y，et al.How commonly is the diagnosis of gastric low grade dysplasia upgraded following endoscopic resection？A meta-analysis[J]．PLoS One，2015，10(7)：e0132699.
|
| [198] |
Kim YJ，Park JC，Kim JH，et al.Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions[J]．Endoscopy，2010，42(8)：620-626.
|
| [199] |
Nam KW，Song KS，Lee HY，et al.Spectrum of final pathological diagnosis of gastric adenoma after endoscopic resection[J]．World J Gastroenterol, 2011，17(47)：5177-83.
|
| [200] |
Jeon HK，Ryu HY，Cho MY，et al.A randomized trial to determine the diagnostic accuracy of conventional vs.jumbo forceps biopsy of gastric epithelial neoplasias before endoscopic submucosal dissection; open-label study[J]．Gastric Cancer，2014，17(4)：661-668.
|
| [201] |
Goo JJ，Choi CW，Kang DH，et al.Risk factors associated with diagnostic discrepancy of gastric indefinite neoplasia：who need en bloc resection？[J]．Surg Endosc，2015，29(12)：3761-3767.
|
| [202] |
Raftopoulos SC，Kumarasinghe P，de Boer B，et al.Gastric intraepithelial neoplasia in a Western population[J]．Eur J Gastroenterol Hepatol, 2012，24(1)：48-54.
|
| [203] |
Pimentel-Nunes P，Mourâo F，Veloso N，et al.Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal[J]．Endoscopy，2014，46(11)：933-940.
|
| [204] |
Pyo JH，Lee H，Min BH，et al.Long-term outcome of endoscopic resection vs. surgery for early gastric cancer：a non-inferiority-matched cohort study[J]．Am J Gastroenterol，2016，111(2)：240-249.
|
| [205] |
Kosaka T，Endo M，Toya Y，et al.Long-term outcomes of endoscopic submucosal dissection for early gastric cancer：a single-center retrospective study[J]．Dig Endosc，2014，26(2)：183-191.
|
| [206] |
Kato M，Nishida T，Yamamoto K，et al.Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group[J]．Gut，2013，62(10)：1425-1432.
|
| [207] |
Horiki N，Omata F，Uemura M，et al.Risk for local recurrence of early gastric cancer treated with piecemeal endoscopic mucosal resection during a 10-year follow-up period[J]．Surg Endosc，2012，26(1)：72-78.
|
| [208] |
Ahn JY，Jung HY，Choi JY，et al.Natural course of noncurative endoscopic resection of differentiated early gastric cancer[J]．Endoscopy，2012，44(12)：1114-1120.
|
| [209] |
Oda I，Gotoda T，Sasako M，et al.Treatment strategy after non-curative endoscopic resection of early gastric cancer[J]．Br J Surg，2008，95(12)：1495-1500.
|
| [210] |
Yoon H，Kim SG，Choi J，et al.Risk factors of residual or recurrent tumor in patients with a tumor-positive resection margin after endoscopic resection of early gastric cancer[J]．Surg Endosc，2013，27：1561-1568.
|
| [211] |
Pimentel-Nunes P，Dinis-Ribeiro M，Ponchon T，et al.Endoscopic submucosal dissection：European Society of Gastrointestinal Endoscopy (ESGE) Guideline[J]．Endoscopy，2015，47(9)：829-854.
|
| [212] |
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3)[J]．Gastric Cancer，2011，14(2)：113-123.
|
| [213] |
Japanese Gastric Cancer Association.Japanese gastric cancer treatment guidelines 2014 (ver. 4)[J]．Gastric Cancer，2017，20(1)：1-19.
|
| [214] |
Lauren P. The two histological main types of gastric carcinoma：diffuse and so-called intestinal-type carcinoma.An attempt at a histo-clinical classification[J]．Acta Pathol Microbiol Scand，1965，64：31-49.
|
| [215] |
Qiu MZ，Cai MY，Zhang DS，et al.Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China[J]．J Transl Med，2013，11：58.
|
| [216] |
Gotoda T，Yanagisawa A，Sasako M，et al.Incidence of lymph node metastasis from early gastric cancer：estimation with a large number of cases at two large centers[J]．Gastric Cancer，2000，3(4)：219-225.
|
| [217] |
Hirasawa T，Gotoda T，Miyata S，et al.Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer[J]．Gastric Cancer，2009，12(3)：148-152.
|
| [218] |
Hasuike N，Ono H，Boku N，et al.A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607) [J]．Gastric Cancer，2018，21(1)：114-123.
|
| [219] |
Probst A，Schneider A，Schaller T，et al.Endoscopic submucosal dissection for early gastric cancer：are expanded resection criteria safe for Western patients? [J]．Endoscopy，2017，49(9)：855-865.
|
| [220] |
Hatta W，Gotoda T，Oyama T，et al.A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer：" eCura system" [J]．Am J Gastroenterol，2017，112(6)：874-881.
|
| [221] |
Facciorusso A，Antonino M，Di Maso M，et al.Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer：a meta-analysis[J]．World J Gastrointest Endosc，2014，6(11)：555-563.
|
| [222] |
Takekoshi T，Baba Y，Ota H，et al.Endoscopic resection of early gastric carcinoma：results of a retrospective analysis of 308 cases[J]．Endoscopy，1994，26(4)：352-358.
|
| [223] |
Hiki Y，Shimao H，Mieno H，et al.Modified treatment of early gastric cancer: evaluation of endoscopic treatment of early gastric cancers with respect to treatment indication groups[J]．World J Surg，1995，19(4)：517-522.
|
| [224] |
Nagano H，Ohyama S，Fukunaga T，et al.Indications for gastrectomy after incomplete EMR for early gastric cancer[J]．Gastric Cancer，2005，8(3)：149-154.
|
| [225] |
Tanabe S，Ishido K，Higuchi K，et al.Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center[J]．Gastric Cancer，2014，17(1)：130-136.
|
| [226] |
Oda I，Gotoda T，Hamanaka H，et al.Endoscopic submucosal dissection for early gastric cancer：technical feasibility，operation time and complications from a large consecutive series[J]．Digestive Endoscopy，2005，17(1)：54-58.
|
| [227] |
Lian J，Chen S，Zhang Y，et al.A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer[J]．GastrointestEndosc，2012，76(4)：763-770.
|
| [228] |
Park YM，Cho E，Kang HY，et al.The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis[J]．Surg Endosc，2011，25(8)：2666-2677.
|
| [229] |
Ono H，Yao K，Fujishiro M，et al.Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer[J]．Dig Endosc, 2016，28(1)：3-15.
|
| [230] |
Farhat S，Chaussade S，Ponchon T，et al.Endoscopic submucosal dissection in a European setting.A multi-institutional report of a technique in development[J]．Endoscopy，2011，43(8)：664-670.
|
| [231] |
Wu CY，Wu MS，Kuo KN，et al.Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients[J]．J Clin Oncol，2010，28(18)：2952-2957.
|
| [232] |
Tian W，Zhao Y，Liu S，et al.Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer[J]．Eur J Cancer Prev，2010，19(4)：288-298.
|
| [233] |
Wang WH，Huang JQ，Zheng GF，et al.Non-steroidal anti-inflammatory drug use and the risk of gastric cancer：a systematic review and meta-analysis[J]．J Natl Cancer Inst，2003，95(23)：1784-1791.
|
| [234] |
Leung WK，Ng EK，Chan FK，et al.Effects of long-term rofecoxib on gastric intestinal metaplasia：results of a randomized controlled trial[J]．Clin Cancer Res，2006，12(15)：4766-4772.
|
| [235] |
Yanaoka K，Oka M，Yoshimura N，et al.Preventive effects of etodolac，a selective cyclooxygenase-2 inhibitor，on cancer development in extensive metaplastic gastritis，a Helicobacter pylori-negative precancerous lesion[J]．Int J Cancer，2010，126(6)：1467-1473.
|
| [236] |
Hung KH，Yang HB，Cheng HC，et al.Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication[J]．J Gastroenterol Hepatol，2010，25(1)：48-53.
|
| [237] |
Yang HB，Cheng HC，Sheu BS，et al.Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication[J]．Aliment Pharmacol Ther，2007，25(4)：455-461.
|
| [238] |
Zhang LJ，Wang SY，Huo XH，et al.Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions[J]．World J Gastroenterol，2009，15(22)：2731-2738.
|
| [239] |
Akre K，Ekström AM，Signorello LB，et al.Aspirin and risk for gastric cancer: a population-based case-control study in Sweden[J]．Br J Cancer，2001，84(7)：965-968.
|
| [240] |
Huang XZ，Chen Y，Wu J，et al.Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk：a dose-response meta-analysis[J]．Oncotarget，2017，8(3)：4781-4795.
|
| [241] |
Correa P，Fontham ET，Bravo JC，et al.Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy[J]．J Natl Cancer Inst，2000，92(23)：1881-1888.
|
| [242] |
You WC，Brown LM，Zhang L，et al.Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions[J]．J Natl Cancer Inst，2006，98(14)：974-983.
|
| [243] |
Plummer M，Vivas J，Lopez G，et al.Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation：a randomized trial in a high-risk population[J]．J Natl Cancer Inst，2007，99(2)：137-146.
|
| [244] |
Ferlay J．Cancer incidence and mortality worldwide. Ervik M，ed. Lyon：France: International Agency for Research on Cancer，2013.
|
| [245] |
Hamashima C，Ogoshi K，Narisawa R，et al.Impact of endoscopic screening on mortality reduction from gastric cancer[J]．World J Gastroenterol，2015，21(8)：2460-2466.
|
| [246] |
Hamashima C，Shabana M，Okada K，et al.Mortality reduction from gastric cancer by endoscopic and radiographic screening[J]．Cancer Sci，2015，106(12)：1744-1749.
|
| [247] |
Hosokawa O，Shinbo T，Matsuda K，et al.Impact of opportunistic endoscopic screening on the decrease of mortality from gastric cancer[J]．J Gastroint Cancer Screen，2011，106：401-407.
|
| [248] |
Riecken B，Pfeiffer R，Ma JL，et al.No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk[J]．Prev Med，2002，34(1)：22-28.
|
| [249] |
Matsumoto S，Yamasaki K，Tsuji K，et al.Results of mass endoscopic examination for gastric cancer in Kamigoto Hospital，Nagasaki Prefecture[J]．World J Gastroenterol，2007，13(32)：4316-4320.
|
| [250] |
Matsumoto S，Yoshida Y．Efficacy of endoscopic screening in an isolated island: a case-control study[J]．Indian J Gastroenterol，2014，33(1)：46-49.
|
| [251] |
Hamashima C，Ogoshi K，Okamoto M，et al.A community-based，case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan[J]．PLoS One，2013，8(11)：e79088.
|
| [252] |
Hosokawa O，Hattori M，Takeda T，et al.Accuracy of endoscopy in detecting gastric cancer[J]．J Gastroenterol Mass Surv，2004，14：33-39.
|
| [253] |
Choi KS，Jun JK，Park EC，et al.Performance of different gastric cancer screening methods in Korea：a population-based study[J]．PLoS One，2012，7(11)：e50041.
|
| [254] |
Hamashima C，Okamoto M，Shabana M，et al.Sensitivity of endoscopic screening for gastric cancer by the incidence method[J]．Int J Cancer，2013，133(3)：653-659.
|
| [255] |
Otsuji M，Kouno Y，Otsuji A，et al.Assessment of small diameter panendoscopy for diagnosis of gastric cancer：comparative study with follow-up survey date[J]．Stomach Intest，1989，24：1291-1297.
|
| [256] |
Gupta N，Bansal A，Wani SB，et al.Endoscopy for upper GI cancer screening in the general population：a cost-utility analysis[J]．Gastrointest Endosc，2011，74(3)：610-624.
|
| [257] |
Lee YC，Lin JT，Wu HM，et al.Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer[J]．Cancer Epidemiol Biomarkers Prev，2007，16(5)：875-885.
|
| [258] |
Areia M，Spaander MC，Kuipers EJ，et al.Endoscopic screening for gastric cancer：a cost-utility analysis for countries with an intermediate gastric cancer risk[J]．United European Gastroenterol J，2018，6(2)：192-202.
|
| [259] |
Shawihdi M，Thompson E，Kapoor N，et al.Variation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer：retrospective analysis of Hospital Episode Statistics[J]．Gut，2014，63(2)：250-261.
|
| [260] |
Leung WK，Ho HJ，Lin JT，et al.Prior gastroscopy and mortality in patients with gastric cancer：a matched retrospective cohort study[J]．Gastrointest Endosc，2018，87(1)：119-127.
|
| [261] |
Carmack SW，Genta RM，Graham DY，et al.Management of gastric polyps: a pathology-based guide for gastroenterologists[J]．Nat Rev Gastroenterol Hepatol，2009，6(6)：331-341.
|
| [262] |
Evans JA，Chandrasekhara V，Chathadi KV，et al.The role of endoscopy in the management of premalignant and malignant conditions of the stomach[J]．Gastrointest Endosc，2015，82(1)：1-8.
|
| [263] |
Graham JR.Gastric polyposis：onset during long-term therapy with omeprazole[J]．Med J Aust，1992，157(9)：287-288.
|
| [264] |
Chandrasekhara V，Ginsberg GG.Endoscopic management of gastrointestinal stromal tumors[J]．Curr Gastroenterol Rep，2011，13(6)：532-539.
|
| [265] |
Islam RS，Patel NC，Lam-Himlin D，et al.Gastric polyps：a review of clinical, endoscopic，and histopathologic features and management decisions[J]．Gastroenterol Hepatol，2013，9(10)：640-651.
|
| [266] |
Han JS，Jang JS，Choi SR，et al.A study of metachronous cancer after endoscopic resection of early gastric cancer[J]．Scand J Gastroenterol，2011，46(9)：1099-1104.
|
| [267] |
Ahn JY，Son DH，Choi KD，et al.Neoplasms arising in large gastric hyperplastic polyps：endoscopic and pathologic features[J]．Gastrointest Endosc，2014，80(6)：1005-1013
|
| [268] |
Kang HM，Oh TH，Seo JY，et al.Clinical factors predicting for neoplastic transformation of gastric hyperplastic polyps[J]．Korean J Gastroenterol，2011，58(4)：184-189.
|
| [269] |
Daibo M，Itabashi M，Hirota T．Malignant transformation of gastric hyperplastic polyps[J]．Am J Gastroenterol，1987，82(10)：1016-1025.
|
| [270] |
Dirschmid K，Platz-Baudin C，Stolte M．Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa？[J]．Virchows Arch，2006，448(1)：80-84.
|
| [271] |
Ginsberg GG，Al-Kawas FH，Fleischer DE，et al.Gastric polyps：relationship of size and histology to cancer risk[J]．Am J Gastroenterol，1996，91(4)：714-717.
|
| [272] |
Rattan J，Arber N，Tiomny E，et al.Gastric polypoid lesions-an eight-year study[J]．Hepatogastroenterology，1993，40(2)：107-109.
|
| [273] |
Hizawa K，Fuchigami T，Iida M，et al.Possible neoplastic transformation within gastric hyperplastic polyp.Application of endoscopic polypectomy[J]．Surg Endosc，1995，9(6)：714-718.
|
| [274] |
Zea-Iriarte WL，Sekine I，Itsuno M，et al.Carcinoma in gastric hyperplastic polypsA phenotypic study[J]．Dig Dis Sci，1996，41(2)：377-386.
|
| [275] |
Cristallini EG，Ascani S，Bolis GB.Association between histologic type of polyp and carcinoma in the stomach[J]．GastrointestEndosc，1992，38(4)：481-484.
|
| [276] |
Harju E．Gastric polyposis and malignancy[J]．Br J Surg，1986，73(7)：532-533.
|
| [277] |
Markowski AR，Markowska A，Guzinska-Ustymowicz K．Pathophysiological and clinical aspects of gastric hyperplastic polyps[J]．World J Gastroenterol，2016，22(40)：8883-8891.
|
| [278] |
Uedo N，Yamaoka R，Yao K．Multiple white flat lesions in the gastric corpus are not intestinal metaplasia[J]．Endoscopy，2017，49(6)：615-616.
|
| [279] |
Hasegawa R，Yao K，Ihara S，et al.Magnified endoscopic findings of multiple white flat lesions：a new subtype of gastric hyperplastic polyps in the stomach[J]．Clin Endosc，2018，51(6)：558-562.
|
| [280] |
Han AR，Sung CO，Kim KM，et al.The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations：a suggestion of indication for endoscopic polypectomy[J]．Gut Liver，2009，3(4)：271-275.
|
| [281] |
Stolte M，Sticht T，Eidt S，et al.Frequency，location，and age and sex distribution of various types of gastric polyp[J]．Endoscopy，1994，26(8)：659-665.
|
| [282] |
Laxén F，Sipponen P，Iham？ki T，et al.Gastric polyps：their morphological and endoscopical characteristics and relation to gastric carcinoma[J]．Acta Pathol Microbio Immunol Scand A，1982，90(3)：221-228.
|
| [283] |
Omori T，Kamiya Y，Tahara T，et al.Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions：a pilot feasibility trial[J]．BMC Gastroenterol，2012，12：17.
|
| [284] |
Kanesaka T，Sekikawa A，Tsumura T，et al.Dense-type crypt opening seen on magnifying endoscopy with narrow-band imaging is a feature of gastric adenoma [J]．Dig Endosc，2014，26(1)：57-62.
|
| [285] |
Yao K，Iwashita A，Nambu M，et al.Nature of white opaque substance in gastric epithelial neoplasia as visualized by magnifying endoscopy with narrow-band imaging[J]．Dig Endosc，2012，24(6)：419-425.
|
| [286] |
Colling C，Asztalos I，Buchner AM，et al.Mo2037 narrow-band imaging classification system for gastric polyps may reduce the need for biopsies[J]．Gastrointest Endosc，2017，85(5)：AB531.
|
| [287] |
Muehldorfer SM，Stolte M，Martus P，et al.Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps：a prospective multicentre study[J]．Gut，2002，50(4)：465-470.
|
| [288] |
Brown H，Wyatt S，Croft S，et al.An evaluation of endoscopycapacity across the NHS in England. London：Cancer Research UK，2015.
|
| [289] |
Ross-Innes CS，Debiram-Beecham I，O'Donovan M，et al.Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus：a multi-center case-control study[J]. PLoS Med，2015，12(1)：e1001780.
|
| [290] |
Dinis-Ribeiro M，da Costa-Pereira A，Lopes C，et al.Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia[J]. Gastrointest Endosc，2003，57(4)：498-504.
|
| [291] |
Guo YT，Li YQ，Yu T，et al.Diagnosis of gastric intestinal metaplasia with confocallaser endomicroscopy in vivo：a prospective study[J]．Endoscopy，2008，40(7)：547-553.
|
| [292] |
Tahara T，Shibata T，Nakamura M，et al.Gastric mucosal pattern byusing magnifying narrow-band imaging endoscopy clearly distinguisheshistological and serological severity of chronic gastritis[J]．Gastrointest Endosc，2009，70(2)：246-253.
|
| [293] |
Capelle LG，Haringsma J，de Vries AC，et al.Narrow band imaging for the detection ofgastric intestinal metaplasia and dysplasia during surveillance endoscopy[J]．Dig Dis Sci，2010，55(12)：3442-3448.
|
| [294] |
Kawamura M，Abe S，Oikawa K，et al.Topographic differences in gastricmicromucosal patterns observed by magnifying endoscopy with narrow bandimaging[J]．J Gastroenterol Hepatol，2011，26(3)：477-483.
|
| [295] |
Rerknimitr R，Imraporn B，Klaikeaw N，et al.Non-sequential narrow band imagingfor targeted biopsy and monitoring of gastric intestinal metaplasia[J]．World J Gastroenterol，2011，17(10)：1336-1342.
|
| [296] |
Dutta AK，Sajith KG，Pulimood AB，et al.Narrow band imaging versus white lightgastroscopy in detecting potentially premalignant gastric lesions：a randomized prospective crossover study[J]．Indian J Gastroenterol，2013，32(1)：37-42.
|
| [297] |
Kanzaki H，Uedo N，Ishihara R，et al.Comprehensive investigation of areaegastricae pattern in gastric corpus using magnifying narrow band imagingendoscopy in patients with chronic atrophic fundic gastritis[J]．Helicobacter，2012，17(3)：224-231.
|
| [298] |
Savarino E，Corbo M，Dulbecco P，et al.Narrow-band imaging with magnifyingendoscopy is accurate for detecting gastric intestinal metaplasia[J]．World J Gastroenterol，2013，19(17)：2668-2675.
|
| [299] |
Fukuta N，Ida K，Kato T，et al.Endoscopic diagnosis of gastric intestinal metaplasia：aprospective multicenter study[J]．Dig Endosc，2013，25(5)：526-534.
|
| [300] |
Pittayanon R，Rerknimitr R，Wisedopas N，et al.Flexible spectral imaging colorenhancement plus probe-based confocal laser endomicroscopy for gastric intestinalmetaplasia detection[J]．J Gastroenterol Hepatol，2013，28(6)：1004-1009.
|
| [301] |
Xirouchakis E，Laoudi F，Tsartsali L，et al.Screening for gastric premalignant lesionswith narrow band imaging，white light and updated Sydney protocol or both? [J]．Dig Dis Sci，2013，58(4)：1084-1090.
|
| [302] |
Nomura S，Ida K，Terao S，et al.Endoscopic diagnosis of gastric mucosal atrophy：multicenter prospective study[J]．Dig Endosc，2014，26(6)：709-719.
|
| [303] |
Sha J，Wang P，Zhu B，et al.Acetic acid enhanced narrow band imaging for thediagnosis of gastric intestinal metaplasia[J]．PLoS One，2017，12：e0170957.
|